Syndevrx Inc

SynDevRx is a biopharmaceutical company based in Cambridge, MA that specializes in Metabo-Oncology, the intersection of cancer and metabolic dysfunction. The company is developing a clinical-stage compound, Evexomostat (SDX-7320), to address the unmet medical need of treating cancer and metabolic hormone imbalance.